A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cells.
作者:
主题词
艾滋病疫苗(AIDS Vaccines);成年人(Adult);细胞因子类(Cytokines);树突细胞(Dendritic Cells);双盲法(Double-Blind Method);酶联免疫吸附测定(Enzyme-Linked Immunosorbent Assay);女(雌)性(Female);基因表达(Gene Expression);基因表达谱(Gene Expression Profiling);HIV抗体(HIV Antibodies);HIV包膜蛋白质gp120(HIV Envelope Protein gp120);HIV包膜蛋白质gp160(HIV Envelope Protein gp160);HIV感染(HIV Infections);HIV-1(HIV-1);人类(Humans);免疫球蛋白G(Immunoglobulin G);注射, 皮内(Injections, Intradermal);注射, 肌肉内(Injections, Intramuscular);白细胞, 单核(Leukocytes, Mononuclear);男(雄)性(Male);试点项目(Pilot Projects);T淋巴细胞, 细胞毒性(T-Lymphocytes, Cytotoxic);时间因素(Time Factors);病毒疫苗(Viral Vaccines)
DOI
10.1371/journal.pone.0024254
PMID
21949699
发布时间
2021-10-20
- 浏览13
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文